SOAP Note for Female Patient ≥85 with Worsening Dizziness on Meclizine
SUBJECTIVE
Chief Complaint: Increased dizziness at 2-week medication follow-up
History of Present Illness:
- Female patient in late 80s presenting with worsening dizziness since last visit, now occurring at least daily
- Currently taking meclizine for dizziness management
- New bilateral lower extremity paresthesias (tingling and numbness)
- Acute back pain following yard work yesterday
- Denies vision changes
- Denies recent falls (but has fall history)
Past Medical History:
- Hyperlipidemia
- Seizure disorder
- Hypertension
- History of falls
Current Medications:
- Meclizine (dose not specified)
- [Antihypertensive medications - specify]
- [Antiepileptic medications - specify]
- [Statin therapy - specify]
OBJECTIVE
Vital Signs: [Document orthostatic vital signs - BP and HR supine and standing at 1 and 3 minutes]
Physical Examination:
- Neurological: Assess bilateral lower extremity sensation (light touch, pinprick, vibration, proprioception); evaluate gait and balance; perform Romberg test; assess for nystagmus
- Cardiovascular: Heart rate, rhythm, presence of murmurs or arrhythmias
- Musculoskeletal: Assess lumbar spine tenderness, range of motion, paraspinal muscle spasm
- Dix-Hallpike maneuver: [Document if performed and results]
ASSESSMENT
Primary Diagnoses:
- R42 - Dizziness and giddiness (worsening despite meclizine therapy)
- R20.2 - Paresthesia of skin, bilateral lower extremities (new onset, concerning for peripheral neuropathy vs. central etiology)
- M54.5 - Low back pain (acute, activity-related)
Chronic Conditions: 4. E78.5 - Hyperlipidemia, unspecified 5. G40.909 - Epilepsy, unspecified, not intractable, without status epilepticus 6. I10 - Essential (primary) hypertension 7. Z91.81 - History of falling
PLAN
Critical Action Items:
1. Discontinue Meclizine Immediately
Meclizine is contraindicated in this clinical scenario and is likely worsening her symptoms. 1, 2 The 2017 AAOHNS guideline explicitly states that vestibular suppressants like meclizine are not routinely recommended for BPPV treatment and significantly increase fall risk in elderly patients, particularly those on polypharmacy 1. The FDA label confirms meclizine causes drowsiness and has anticholinergic effects that impair balance 2.
- Rationale: In elderly patients with seizure disorder and hypertension (polypharmacy), meclizine's anticholinergic properties and CNS depression effects substantially increase fall risk 1. Her worsening dizziness on meclizine suggests either medication-induced adverse effects or an underlying condition requiring different management.
2. Urgent Workup for New Bilateral Lower Extremity Paresthesias
Order immediately:
- Comprehensive metabolic panel (assess for metabolic causes, renal function affecting medication clearance)
- HbA1c and fasting glucose (diabetic neuropathy screening)
- Vitamin B12 and folate levels (nutritional neuropathy)
- TSH (thyroid-related neuropathy)
- Review antiepileptic drug levels if applicable (medication toxicity)
Consider urgent neurology referral if:
- Paresthesias progress proximally
- Weakness develops
- Bowel/bladder dysfunction emerges
- Gait becomes significantly impaired
Rationale: New bilateral lower extremity paresthesias in an elderly patient with multiple comorbidities requires immediate evaluation to exclude serious etiologies including medication toxicity, metabolic derangements, or evolving neurological conditions 3, 4.
3. Evaluate for Vestibular Causes of Dizziness
If not already performed, conduct:
- Dix-Hallpike maneuver to assess for benign paroxysmal positional vertigo (BPPV)
- HINTS examination (Head Impulse, Nystagmus, Test of Skew) if acute vestibular syndrome suspected 5
- Orthostatic vital signs (measure BP/HR supine and at 1 and 3 minutes standing) to evaluate for orthostatic hypotension
If BPPV confirmed: Perform Epley maneuver (canalith repositioning procedure) - this is first-line treatment with 78.6-93.3% improvement rates, vastly superior to medication alone (30.8%) 1.
Rationale: The 2017 guideline emphasizes that particle repositioning maneuvers are the definitive treatment for BPPV, not medications 1. Elderly patients with hypertension and polypharmacy are at particularly high risk for orthostatic hypotension contributing to dizziness 3, 4.
4. Medication Review and Optimization
Review ALL current medications for:
- Drug-drug interactions (particularly antiepileptics with antihypertensives)
- Medications contributing to dizziness (antihypertensives, antiepileptics, anticholinergics)
- CYP2D6 interactions if meclizine was recently used 2
Adjust antihypertensive regimen if orthostatic hypotension present - consider reducing doses or switching agents.
Rationale: Polypharmacy is a major independent risk factor for falls in elderly patients 1. Hypertension and seizure disorder management requires careful medication selection to avoid exacerbating dizziness 6.
5. Back Pain Management
Conservative management:
- NSAIDs (if no contraindications with renal function, cardiovascular disease)
- Acetaminophen (safer in elderly)
- Ice/heat therapy
- Activity modification
- Physical therapy referral if pain persists >2 weeks
Red flag assessment: Document absence of fever, weight loss, neurological deficits, bowel/bladder dysfunction.
6. Fall Prevention Strategy
Implement immediately:
- Home safety evaluation (consider occupational therapy referral)
- Physical therapy for gait and balance training
- Assistive device assessment (cane, walker)
- Educate patient and family on fall risk
Rationale: Patient has history of falls and multiple risk factors (age >85, dizziness, polypharmacy, neuropathy symptoms) 1.
7. Follow-up
Reassess within 1 week (not 1 month given worsening symptoms and new paresthesias) 1:
- Document resolution or persistence of dizziness after meclizine discontinuation
- Review laboratory results
- Assess paresthesia progression
- Evaluate back pain response to treatment
Consider vestibular rehabilitation referral if symptoms persist after addressing reversible causes.
CPT CODES
- 99214 - Office visit, established patient, moderate complexity (30-39 minutes) - appropriate given multiple problems addressed, medication adjustment, and coordination of care
- 95992 - Canalith repositioning procedure (if Epley maneuver performed)
- 95199 - Unlisted neurological procedure (if HINTS examination performed and documented)
ICD-10 CODES
Primary:
- R42 - Dizziness and giddiness
- R20.2 - Paresthesia of skin (bilateral lower extremities)
- M54.5 - Low back pain
Secondary (Chronic):
- E78.5 - Hyperlipidemia, unspecified
- G40.909 - Epilepsy, unspecified, not intractable, without status epilepticus
- I10 - Essential (primary) hypertension
- Z91.81 - History of falling
Key Clinical Pearls:
- Meclizine worsens outcomes in elderly patients with dizziness - it does not address underlying vestibular pathology and significantly increases fall risk through sedation and anticholinergic effects 1, 2.
- New bilateral paresthesias demand urgent workup - this is NOT a typical presentation of benign dizziness and may indicate serious underlying pathology 3, 4.
- Polypharmacy in elderly patients with seizures and hypertension creates complex drug interactions - systematic medication review is essential 1, 6.
- Physical maneuvers (Epley) are vastly superior to medications for BPPV - 78-93% vs. 31% improvement 1.